FNDC9
Fibronectin type III domain-containing protein 9
Also known as: C5orf40, FNDC9_HUMAN, MGC27121
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8TBE3
- Gene
- FNDC9
- Ensembl
- ENSG00000172568
- Chromosome
- 5
- Canonical length
- 224 aa
- Protein class
- Predicted membrane proteins
OverviewNCBI Gene
Predicted to be located in membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
224 residues, UniProt reviewed canonical sequence.
>Q8TBE3|FNDC9
1 MNIEVGNISY TGAIISWSSS EPCLEDYYHI MYRPNWNSIF SGYLRYSFHH EEKVPRTISS
61 VVLEHLAPST LYFLCISCKK AAFPYRHYCT MFHTLDKSPL APGSSLVDPQ ISLWVLMAIL
121 LACFTAVLAF ICLQFWCVRC HEPRWSYRAG HMEEANGLVR WPEEAPDLGQ REEDLQGLPL
181 VEMPRKNSRD GAELDPEANQ DAPDAGALQR GGGDPPAILP HCGELocalizationUniProt · AlphaFold · HPA
Whether an antibody against FNDC9 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.53
- Highest tissue expression
- 27 nTPM
Expression across tissuesHPA
Tissue
- hypothalamus: 27 nTPM
- basal ganglia: 16 nTPM
- cerebral cortex: 11 nTPM
- pituitary gland: 11 nTPM
- cerebellum: 8.3 nTPM
- adrenal gland: 4.5 nTPM
Single-cell type
- other brain neurons: 13 nCPM
- brain inhibitory neurons: 3.9 nCPM
- brain excitatory neurons: 3.2 nCPM
- loop of henle epithelial cells: 1.9 nCPM
- renal collecting duct principal cells: 1.3 nCPM
- renal collecting duct intercalated cells: 0.7 nCPM
Immune cell
- gdT-cell: 0.2 nTPM
- naive CD8 T-cell: 0.2 nTPM
- eosinophil: 0.1 nTPM
- memory CD8 T-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
Brain region
- hypothalamus: 84 nTPM
- cerebral cortex: 23 nTPM
- midbrain: 20 nTPM
- medulla oblongata: 19 nTPM
- cerebellum: 17 nTPM
- pons: 16 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.35
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.03
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FNDC9 as an antibody target. Whether an autoantibody or antibody against FNDC9 could matter depends on whether native FNDC9 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FNDC9 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FNDC9 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...